| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.8B | $7.7B | $7.0B | $6.6B | $7.3B | $1.5B | $1.5B | $1.3B |
| Cost of Revenue | $6.6B | $6.6B | $6.0B | $5.7B | $6.5B | $5.1B | $5.0B | $4.5B |
| Gross Profit | $1.1B | $1.1B | $1.0B | $0.8B | $0.8B | $0.2B | $0.2B | $0.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.6B | $0.5B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | — |
| Operating Income | $0.8B | $0.7B | $0.4B | $0.3B | $0.2B | $0.0B | $0.1B | $0.1B |
| Net Income | $0.4B | $0.4B | $-0.3B | $0.2B | $0.0B | $0.0B | $0.1B | $0.0B |
| EPS (Basic) | $3.21 | $2.79 | $-1.96 | $1.36 | $0.13 | $0.14 | $0.41 | $0.31 |
| EPS (Diluted) | $3.21 | $2.79 | $-1.96 | $1.26 | $0.12 | $0.13 | $0.40 | $0.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.6B | $6.7B | $5.6B | $5.6B | $6.2B | $5.7B | $5.4B | $5.1B |
| Current Assets | $2.1B | $1.9B | $1.7B | $1.7B | $2.2B | $1.6B | $2.0B | $2.0B |
| Cash & Equivalents | $0.5B | $0.3B | $0.3B | $0.4B | $0.4B | $0.4B | $0.7B | $0.7B |
| Total Liabilities | $5.1B | $5.2B | $4.2B | $3.9B | $4.5B | $4.1B | $3.5B | $3.3B |
| Current Liabilities | $1.7B | $1.8B | $1.6B | $1.8B | $1.9B | $1.5B | $1.5B | $1.4B |
| Stockholders' Equity | $1.5B | $1.5B | $1.4B | $1.6B | $1.7B | $1.6B | $1.8B | $1.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | $0.5B | $0.3B | $0.4B | $0.3B | $0.4B | $0.3B | $0.2B |
| Investing Cash Flow | — | $-0.8B | $-0.1B | $0.0B | $-0.4B | $-0.9B | $-0.2B | $-0.5B |
| Capital Expenditures | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | — | — | — |
| Financing Cash Flow | — | $0.4B | $-0.4B | $-0.4B | $0.1B | $0.2B | $-0.1B | $0.7B |